Exela Technologies, Inc., a leading provider of Business Process Automation solutions, today announced that it has been recognized as a ‘Major Player’ in the IDC MarketScape for U.S. RCM Service Solutions 2022-2023 Vendor Assessment.
Revenue Cycle Management (RCM) is the process by which a health system bills for services and generates revenue. RCM typically covers the entire patient journey, from a patient’s first appointment all the way through to the payor’s acceptance of final payment.
This IDC MarketScape assesses RCM service solutions currently available in the U.S. market. This study aims to provide technology buyers with insight into the strategies, capabilities, and criteria healthcare organizations should consider when selecting an RCM service solution.
Read More: Tredence Raises $175 Mn In Series B Funding From Advent International
The report calls out Exela’s strength in Delivery Models and Workflow Automation. It describes the combination of robust end-to-end RCM capabilities, subject matter expertise, and innovation as a key strength that has allowed Exela Technologies to consistently deliver its services for over 30 years and with high customer satisfaction.
“We are pleased to announce that IDC has named Exela as a MAJOR PLAYER in the IDC MarketScape for U.S. RCM Service,” said Kevin Lathrop, Exela’s President of Healthcare Services. “Our PCH Global solution provides a connected ecosystem to improve action on claims and collection rates while reducing cost-to-collect and bad-debt write-offs. Exela works as a trusted partner to health organizations to minimize inherent complexity and eliminate administrative burden while delivering unparalleled quality and significant value.”
Read More: SalesTechStar Interview with Jeff Santelices, CRO at MindTickle
